Welcome to our dedicated page for 3M news (Ticker: MMM), a resource for investors and traders seeking the latest updates and insights on 3M stock.
3M Company reports recurring developments across its science-based industrial, transportation and electronics, and consumer businesses. Company updates commonly cover quarterly results, guidance, margins, cash flow, portfolio reshaping, transformation costs, PFAS and litigation-related items, and capital-structure activity.
News also includes product and capacity updates tied to 3M technologies and brands, including 3M Expanded Beam Optical interconnect solutions for data centers and Scotch-Brite consumer cleaning products. Other recurring themes include investor events, board and leadership appointments, government affairs, and manufacturing investments linked to the company's global operations.
3M reported its third-quarter 2022 results with GAAP earnings per share of $6.77 and adjusted earnings per share of $2.69. Sales reached $8.6 billion, a 4% year-on-year decline, impacted by divestitures and foreign currency translation effects. Organic sales growth was 2%, driven down by disposable respirator demand. Operating cash flow decreased by 18% to $1.5 billion. The company returned $1.0 billion to shareholders. 3M updated its full-year sales and earnings outlook, reflecting a challenging macroeconomic environment.
3M has launched the 3M Filtek Matrix, a new restorative dental solution designed to enhance patient care while reducing costs. This innovative system enables a less invasive procedure, using digital design to create a patient-specific matrix for composite placement. It allows dentists to perform restorations with increased confidence and efficiency, improving chair time and aesthetic outcomes. Clinicians can integrate the Filtek Matrix with 3M Dental Restoratives for optimal strength. The product aims to cater to the growing demand for affordable dental care.
Summary not available.
3M Health Care's Medical Solutions Division announced that its 3M™ V.A.C.® Therapy negative pressure wound therapy (NPWT) has surpassed a significant clinical milestone with over 2,000 peer-reviewed studies published. This achievement highlights V.A.C. Therapy as the most clinically supported NPWT solution, accounting for 75% of all published NPWT evidence. The studies cover a variety of wound types and care settings, promoting innovations in wound management. With continuous product evolution, 3M focuses on enhancing patient outcomes and clinician efficiency in wound care.
3M has launched the Post-it® App for Microsoft Teams, enhancing collaboration in hybrid work environments. This app enables users to create and share Post-it® Notes digitally, bridging the gap between physical and digital brainstorming. Key features include smartphone integration for capturing handwritten notes, 'Zen Mode' for focused work, and tools for achieving consensus among team members. The app supports inclusive collaboration and is available for a free 30-day trial on Microsoft AppSource.
3M has launched its next-generation Scotchlite Reflective Material Industrial Wash Transfer Films, designed for durability in harsh washing conditions. The 9725 Transfer Film withstands up to 75 industrial wash cycles and 50 disinfectant washes, while the 9745 Flame Resistant Film lasts up to 100 industrial cycles. Both products comply with the Oeko-Tex Standard 100, emphasizing sustainability. Developed with leading detergent suppliers, these innovations aim to enhance safety in various industries, including construction and manufacturing, while reducing ownership costs.
ST. PAUL, Minn., Oct. 4, 2022 /PRNewswire/ -- 3M (NYSE: MMM) has announced its upcoming third-quarter 2022 earnings conference call scheduled for Tuesday, Oct. 25, 2022, at 8 a.m. CDT. Investors can join the call by dialing (800) 762-2596 within the U.S. or +1 (212) 231-2916 from abroad. A live webcast will also be available, with a replay accessible on 3M's Investor Relations website, investors.3M.com.
3M (NYSE: MMM) has finalized the sale of its rights to the Neoplast™ and Neobun™ brands along with associated assets in Thailand and parts of Southeast Asia to Selic Corp Public Company Limited. This divestment is in line with 3M's strategy to optimize its portfolio, focusing on higher-value areas. The deal includes the manufacturing assets from the Ladlumkaew facility. Although the sale will not materially impact 3M's financial results, it reflects ongoing efforts to enhance returns for shareholders.
3M's Health Information Systems division announced that its M*Modal Fluency Direct and medical necessity solutions will be integrated into Epic's Garden Plot software. Designed for independent medical groups of 40+ providers, this Software as a Service (SaaS) model aims to enhance patient care. Approximately half of U.S. physicians practice in private settings, indicating significant market potential. This collaboration reflects a long-standing relationship with Epic, expanding access to advanced healthcare technology.
Epicore Biosystems has announced a collaboration with 3M and Innovize to enhance the development of its advanced sweat-sensing wearables. This partnership aims to leverage 3M's skin-interfacing materials and Innovize's manufacturing capabilities to improve production efficiency and support high-volume manufacturing of hydration monitoring devices. With rising temperatures increasing heat-related risks, this initiative ensures a robust domestic production infrastructure while expanding Epicore's portfolio of clinically validated products. The collaboration aims to address hydration management in sports and industrial settings.